05/09/08 - Lannett Chairman Transfers Five Million Shares Of Stock...more

04/30/08 - Lannett Company To Remain A Major Marketer Of Digoxin Tablets...more

04/24/08 - Lannett Company Receives Approval For Dipyridamole Tablets USP, 25MG, 50MG, And 75MG...more

03/31/08 - Lannett Company Receives FDA Approval For Rifampin Capsules USP, 150MG And 300MG...more

03/28/08 - Lannett Company Receives FDA Approval For Bethanechol Chloride Tablets USP, 5MG, 10MG, 25MG, And 50MG...more

02/13/08 - Lannett Company To Present At Roth 20th Annual Growth Stock Conference...more

02/11/08 - Lannett Company Encouraged By Levothyroxine Development In Florida...more

02/08/08 - Lannett Company Reports Fiscal 2008 Second Quarter Financial Results...more

12/12/07 - Lannett Receives FDA Approval For Phentermine...more

11/12/07 - Lannett Company Reports Fiscal 2008 First Quarter Financial Results...more

11/12/07 - Lannett Company, Inc. And Subsidiaries Consolidated Condensed Balance Sheets...more

11/12/07 - Lannett Company, Inc. And Subsidiaries Consolidated Statements Of Operations...more

10/10/07 - Lannett Company Comments On Recent FDA Announcement For Levothyroxine Sodium...more

10/10/07 - Lannett Company Files Form 10-K For Year Ended June 30, 2007; Final Audited Report In Line With Preliminary Financial Results Previously Announced...more

10/01/07 - Lannett Company, Inc. And Subsidiaries Preliminary And Unaudited Consolidated Statements Of Operations...more

10/01/07 - Lannett Reports Preliminary Unaudited Fiscal 2007 Financial Results...more

07/12/07 - Lannett Company Receives Approval To Market Baclofen 10MG Tablets...more

05/30/07 - Lannett Company To Present AT FTN Midwest HealthCare Conference...more

05/08/07 - Lannett Company, Inc. And Subsidiaries Consolidated Statements Of Operations...more

05/08/07 - Lannett Company, Inc. And Subsidiaries Consolidated Condense Balanced Sheets...more

05/08/07 - Lannett Company Reports Fiscal 2007 Third Quarter Financial Results...more

05/01/07 - Lannett Company UBS Conference Release...more

04/23/07 - Lannett Company Receives Approval For Danazol...more

04/12/07 - Lannett Company Bulk Raw Materials Acquisition...more

02/08/07 - Lannett Company Reports Fiscal 2007 Second Quarter Financial Results...more

01/11/07 - Lannett Company to Commence Marketing Meloxicam for Arthritis...more

01/09/07 - Lannett Company Signs Supply Agreement with Banner Pharmacaps...more

01/03/07 - Lannett Company Signs Research Agreement with Pharmaseed Bioservices...more

11/08/06 - Lannett Company Reports Fiscal 2007 First Quarter Financial Results...more

09/13/06 - Lannett Company Reports Fiscal 2006 Fourth Quarter and Full-Year Financial Results...more

08/16/06 - Lannett Company Announces Plan to Expand Facilities...more

06/26/06 - Lannett Company Signs Supply Agreement with Olive Healthcare...more

05/30/06 - Lannett Company to Present at FTN Midwest Healthcare Conference...more

05/22/06 - Lannett Company Receives Approval for Probenecid Tablets 500 mg, USP...more

05/19/06 - Lannett Company Announces New Board Member...more

05/10/06 - Lannett Company Reports Fiscal 2006 Third Quarter Financial Results...more

03/30/06 - Lannett Company Signs Agreement With Swiss Company, Azad Pharma AG, To Jointly Develop, Commercialize Products...more

02/21/06 - WEBCAST REGISTRATION: Lannett Company Presentation at Roth Capital Investment Conference

02/21/06 - Lannett Company To Present at the Roth Capital Partners 18TH Annual OC Conference...more

02/15/06 - Lannett Company CEO Purchases Stock...more

02/09/06 - Lannett Company Reports Fiscal 2006 Second Quarter Financial Results...more